![](https://cdn.sanity.io/images/0vv8moc6/oncnurse/bf12b3fe884653ae6aff5e1d4008892a11845f6b-4537x2684.jpg?fit=crop&auto=format)
Higher Corticosteroid Peak Dose May Worsen Survival in Patients With Treatment-Related Adverse Events
Patients who received higher corticosteroid peak dose for treatment-related adverse events (trAEs) upon treatment with anti-PD-1 and anti-CTLA-4 therapy had worse survival across tumor sites, although this association was not observed with a cumulative …